RNS Number : 9425V
Tavistock Investments PLC
11 July 2024
 

11 July 2024

Tavistock Investments Plc

("Tavistock" or the "Company")

 

Follow up to Titan termination announcement

 

 

Tavistock confirms the accuracy of the announcement that it made to the market on 8 July 2024.  The table below demonstrates the unacceptable performance by Titan.

 

  

Performance  27th Aug 22 - 4th Jan 24


Performance vs Benchmark

Quartile Rank

Fund Rank

Percentile Rank

ACUMEN Portfolio 4

-7.89%

4th

176/177

100th

ACUMEN Portfolio 5

-8.27%

4th

177/177

100th

ACUMEN Portfolio 6

-9.72%

4th

212/215

99th

ACUMEN Portfolio 7

-11.19%

4th

214/215

100th

ACUMEN Portfolio 8

-13.51%

4th

157/159

99th

Average

-10.12%

4th

 

100th

Source of data: FE Analytics

 A claim against Titan has been intimated and is being progressed by Tavistock's legal representatives.

The statement made to the press by Titan on 9 July 2024 appears to reflect Titan's view of the dispute, following Tavistock's decision to terminate.  Tavistock strongly denies the suggestion of wrongful conduct and considers that Titan's allegations are false and have been put forward as a retaliatory step.

The matter is now subject to pre-action correspondence and Tavistock does not propose to comment further at this stage.

 

    For further information:

 

Tavistock Investments Plc



Oliver Cooke

Tel: 01753 867000

Brian Raven

 



Allenby Capital Limited

(Nominated adviser and broker)

Corporate Finance:

Nick Naylor, Liz Kirchner, Daniel Dearden-Williams

Sales and Corporate Broking:

Tony Quirke

 

Tel: 020 3328 5656

 



 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURFLFIDDIIILIS